Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (2): 97-100.DOI: 10.3969/j.issn.1673-8640.2018.02.001

• Orginal Article •     Next Articles

Combined determination of serum amyloid A protein,cystatin C and urinary albumin-to-creatinine ratio in the diagnosis of early diabetic nephropathy

ZHANG Rulin, WANG Hongming, PENG Xia, LI Jiayong, LI Li   

  1. Department of Clinical Laboratory,Shanghai General Hospital,Shanghai 200080,China
  • Received:2017-05-09 Online:2018-02-28 Published:2018-03-02

Abstract:

Objective To investigate the combined determination of serum amyloid A protein(SAA),cystatin C(Cys C) and urinary albumin-to-creatinine ratio(ACR) in the diagnosis of early diabetic nephropathy(DN). Methods A total of 100 patients with type 2 diabetes mellitus(T2DM) and 100 patients with early DN were enrolled,and 50 healthy subjects were enrolled as healthy control group. The levels of serum SAA and Cys C and urinary ACR were determined. Pearson correlation analysis was performed,and receiver operating characteristic(ROC) curve was used. Results Serum SAA and Cys C levels and urinary ACR increased in turn in healthy control,T2DM and DN groups(P<0.05). Serum SAA and Cys C levels and urinary ACR in DN group were positively correlated(r=0.631 and 0.662,P<0.05). The area under ROC curve of the combined determination of serum SAA,Cys C and urinary ACR was bigger than those of the combined determinations of 2 items and single determinations. Conclusions The combined determination of serum SAA,Cys C and urinary ACR has higher accuracy than those of single determinations in the diagnosis of early DN.

Key words: Amyloid A protein, Cystatin C, Albumin-to-creatinine ratio, Diabetic nephropathy

CLC Number: